Amarin Corp Plcuk (AMRN) Other Working Capital Changes (2010 - 2026)
Amarin Corp Plc\Uk (AMRN) posted quarterly Other Working Capital Changes of $291000.0 for Q2 2026, down 26.7% year-over-year from $397000.0 in Q2 2025, and up 136.59% quarter-over-quarter from $123000.0 in Q1 2026.
Amarin Corp Plcuk (AMRN) Other Working Capital Changes (2010 - 2026) Analysis & Trends
Amarin Corp Plc\Uk (AMRN) has reported Other Working Capital Changes for 13 consecutive years, with $291000.0 the latest figure, recorded in Q2 2026.
- In Q2 2026, Other Working Capital Changes fell 26.7% year-over-year to $291000.0; the TTM figure through Jun 2026 stood at -$628000.0 (down 3825.0% YoY), while the FY2025 annual figure was -$1.1 million, up 78.19% from the prior year.
- Other Working Capital Changes grew to $291000.0 in Q2 2026 per AMRN's latest filing, from $123000.0 in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $23.4 million in Q2 2023 and bottomed at -$24.4 million in Q3 2024.
- Historically, Other Working Capital Changes has averaged $519111.1 across 5 years, with a median of $1.2 million in 2023.
- On a YoY basis, Other Working Capital Changes climbed as much as 1080.95% in 2022 and fell as far as 835.7% in 2022.
- Amarin Corp Plc\Uk's Other Working Capital Changes stood at -$4.0 million in 2022, then soared by 96.87% to -$124000.0 in 2023, then plunged by 3487.9% to -$4.4 million in 2024, then soared by 79.16% to -$927000.0 in 2025, then soared by 131.39% to $291000.0 in 2026.
- Business Quant data shows AMRN's Other Working Capital Changes at $291000.0 in Q2 2026, $123000.0 in Q1 2026, and -$927000.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 653.59 Bn | 632.83 Bn | 17.26 Bn |
| 2 | AbbVie | 470.48 Bn | 463.91 Bn | 12.70 Bn |
| 3 | Merck | 375.12 Bn | 367.98 Bn | 12.21 Bn |
| 4 | Novartis Ag | 302.96 Bn | 295.27 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.26 Bn | 252.36 Bn | 12.86 Bn |
| 6 | Amgen | 237.14 Bn | 223.15 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 182.99 Bn | 179.82 Bn | 6.22 Bn |
| 8 | Pfizer | 160.23 Bn | 148.53 Bn | 10.94 Bn |
| 9 | Gsk | 106.11 Bn | 101.94 Bn | 8.24 Bn |
| 10 | Amarin Corp Plcuk | 5.90 Bn | 5.58 Bn | 14.99 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 4.72 Mn |
| Jun 30, 2026 | 4.72 Mn |
| Jun 30, 2026 | 4.72 Mn |
| Mar 31, 2026 | 1.97 Mn |
| Mar 31, 2026 | 1.97 Mn |
| Mar 31, 2026 | 1.97 Mn |
| Dec 31, 2025 | -4.80 Mn |
| Dec 31, 2025 | -4.80 Mn |
| Dec 31, 2025 | -4.80 Mn |
| Sep 30, 2025 | 12.02 Mn |
| Sep 30, 2025 | 12.02 Mn |
| Sep 30, 2025 | 12.02 Mn |
| Jun 30, 2025 | -7.34 Mn |
| Jun 30, 2025 | -7.34 Mn |
| Jun 30, 2025 | -7.34 Mn |
| Mar 31, 2025 | 12.58 Mn |
| Mar 31, 2025 | 12.58 Mn |
| Mar 31, 2025 | 12.58 Mn |
| Dec 31, 2024 | 5.41 Mn |
| Dec 31, 2024 | 5.41 Mn |